BioStem Technologies to Sponsor MRO Better Half Dash
29 mai 2024 11h00 HE
|
Biostem Technologies
BioStem Technologies to Sponsor MRO Better Half Dash
BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million
14 mai 2024 16h01 HE
|
Biostem Technologies
BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million
BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
07 mai 2024 08h00 HE
|
Biostem Technologies
BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts
30 avr. 2024 08h30 HE
|
Biostem Technologies
BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts
BioStem Technologies to Present at the 2024 Planet MicroCap Showcase
25 avr. 2024 08h00 HE
|
Biostem Technologies
BioStem Technologies to Present at the 2024 Planet MicroCap Showcase
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange
24 avr. 2024 08h00 HE
|
Biostem Technologies
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange
BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference
02 avr. 2024 08h00 HE
|
Biostem Technologies
BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference
BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase
01 avr. 2024 16h05 HE
|
Biostem Technologies
BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase
BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024
21 mars 2024 08h00 HE
|
Biostem Technologies
BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024
PRISM MarketView Spotlights BioStem Technologies in the Expanding Wound Care Market
26 févr. 2024 10h39 HE
|
PRISM MarketView
PRISM MarketView Highlights BioStem Technologies as it Targets Significant Opportunity in Wound Care Markets